Zinzino
February 25, 2026
GOTHENBURG, Sweden -- February 25, 2026
Zinzino reported fourth-quarter 2025 revenue of 1,035.3 million Swedish kronor, up 45 percent from 713.5 million kronor a year earlier, or 52 percent in local currencies. EBITDA rose to 175.2 million kronor, a margin of 16.9 percent compared with 10.2 percent, and net profit increased to 123.7 million kronor, or 3.41 kronor per share, from 43.2 million kronor. Operating cash flow was 271.5 million kronor.
For the full year, revenue grew 51 percent to 3,337.5 million kronor, EBITDA reached 443.4 million kronor for a 13.3 percent margin, and net profit was 324.5 million kronor, or 9.09 kronor per share. During the fourth quarter Zinzino acquired a 35 percent stake in Xion, agreed to acquire the assets of Mexico-based direct seller Sanki and launched a Gut Health Test.
The board proposed a dividend of 6.00 kronor per share, up 50 percent from 4.00 kronor, for approval at the annual general meeting on June 2, 2026. The company combined with U.S. direct seller It Works! in January.